1-3 of 3
letermovir
Close
Sort by
Journal Articles

Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients

Clinical Trials & Observations
Joshua A. Hill, Danniel Zamora, Hu Xie, Laurel A. Thur, Colleen Delaney, Ann Dahlberg, Steven A. Pergam, Wendy M. Leisenring, Michael Boeckh, Filippo Milano
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3113–3119.
https://doi.org/10.1182/bloodadvances.2021004362
Published: 2021
Includes: Supplemental data
Journal Articles

Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation

Clinical Trials & Observations
Satoshi Kaito, Yujiro Nakajima, Konan Hara, Takashi Toya, Tetsuya Nishida, Naoyuki Uchida, Junichi Mukae, Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Kazuhiro Ikegame, Yuta Katayama, Takuro Kuriyama, Junya Kanda, Yoshiko Atsuta, Masao Ogata, Ayumi Taguchi, Kazuteru Ohashi
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1051–1061.
https://doi.org/10.1182/bloodadvances.2019000814
Published: 2020
Includes: Supplemental data
Journal Articles

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Kaiwen Chen, Matthew P. Cheng, Sarah P. Hammond, Hermann Einsele, Francisco M. Marty
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2159–2175.
https://doi.org/10.1182/bloodadvances.2018016493
Published: 2018
Includes: Supplemental data